PubRank

Ajith K Siriwardena

Author PubWeight™ 58.49‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Determinant-based classification of acute pancreatitis severity: an international multidisciplinary consultation. Ann Surg 2012 5.55
2 Open pancreatic necrosectomy in the multidisciplinary management of postinflammatory necrosis. Ann Surg 2010 2.97
3 Mesh fixation at laparoscopic inguinal hernia repair: a meta-analysis comparing tissue glue and tack fixation. World J Surg 2014 2.66
4 EGFR and KRAS mutational analysis and their correlation to survival in pancreatic and periampullary cancer. Pancreas 2012 1.65
5 European survey of surgical strategies for the management of severe acute pancreatitis. Am J Gastroenterol 2004 1.56
6 The liver-first approach to the management of colorectal cancer with synchronous hepatic metastases: a systematic review. JAMA Surg 2013 1.52
7 The end of cryotherapy for the treatment of nonresectable hepatic tumors? Ann Surg Oncol 2005 1.40
8 Radiofrequency ablation of liver tumours: systematic review. Lancet Oncol 2004 1.38
9 Systematic appraisal of the role of metallic endobiliary stents in the treatment of benign bile duct stricture. Ann Surg 2005 1.30
10 Systematic appraisal of the management of the major vascular complications of pancreatitis. Am J Surg 2005 1.22
11 Role of tumor necrosis factor-alpha in acute pancreatitis: from biological basis to clinical evidence. Shock 2007 1.13
12 Current status of tumor M2 pyruvate kinase (tumor M2-PK) as a biomarker of gastrointestinal malignancy. Ann Surg Oncol 2007 1.11
13 Markers of angiogenesis in synchronous and in metachronous colorectal hepatic metastases. Ann Surg 2015 1.08
14 Understanding the colonic complications of pancreatitis. Pancreatology 2008 1.04
15 Cholecystitis after cholecystectomy. J R Soc Med 2002 1.00
16 Radiofrequency ablation for locally advanced cancer of the pancreas. JOP 2006 0.99
17 Evidence for a central role for selective mesenteric angiography in the management of the major vascular complications of pancreatitis. Am J Surg 2003 0.98
18 Quality of life assessment in patients with chronic pancreatitis receiving antioxidant therapy. World J Gastroenterol 2010 0.95
19 Radiofrequency ablation of the pancreas. II: Intra-operative ablation of non-resectable pancreatic cancer. A description of technique and initial outcome. JOP 2005 0.94
20 Development and validation of an experimental model for the assessment of radiofrequency ablation of pancreatic parenchyma. Pancreas 2005 0.94
21 Effects of thalidomide in a mouse model of cerulein-induced acute pancreatitis. Shock 2008 0.93
22 TNF-alpha as a therapeutic target in acute pancreatitis--lessons from experimental models. ScientificWorldJournal 2007 0.90
23 Diagnostic and prognostic value of plasma tumor M2 pyruvate kinase in periampullary cancer: evidence for a novel biological marker of adverse prognosis. Pancreas 2007 0.89
24 Experimental and clinical evidence for modification of hepatic ischaemia-reperfusion injury by N-acetylcysteine during major liver surgery. HPB (Oxford) 2011 0.89
25 Centralisation of upper gastrointestinal cancer surgery. Ann R Coll Surg Engl 2007 0.89
26 Etanercept attenuates the development of cerulein-induced acute pancreatitis in mice: a comparison with TNF-alpha genetic deletion. Shock 2007 0.88
27 Nutritional and anthropometric assessment of the scope for dietary optimization during staging prior to pancreaticoduodenectomy. JOP 2008 0.87
28 Epidermal growth factor receptor in pancreatic cancer. Cancers (Basel) 2011 0.87
29 Sequential endovascular repair and pancreaticoduodenectomy for abdominal aortic aneurysm copresenting with periampullary cancer. Ann Vasc Surg 2006 0.83
30 Inhibition of tyrosine-kinase-mediated cellular signaling by tyrphostins AG 126 and AG556 modulates murine experimental acute pancreatitis. Surgery 2005 0.82
31 Current status of laparoscopic biliary bypass in the management of non-resectable peri-ampullary cancer. Pancreatology 2005 0.82
32 Drotrecogin alfa (recombinant human activated protein C) in severe acute pancreatitis. Crit Care 2005 0.82
33 Intravenous selenium modulates L-arginine-induced experimental acute pancreatitis. JOP 2005 0.81
34 The performance of organ dysfunction scores for the early prediction and management of severity in acute pancreatitis: an exploratory phase diagnostic study. Pancreas 2010 0.80
35 Recombinant human activated protein C (Xigris) attenuates murine cerulein-induced acute pancreatitis via regulation of nuclear factor κB and apoptotic pathways. Pancreas 2012 0.80
36 Pathways of care for patients with suspected cancer of the pancreas: a tiered questionnaire-based survey of medical personnel across a single United kingdom Calman-Hine cancer network. JOP 2005 0.80
37 Green tea polyphenols ameliorate pancreatic injury in cerulein-induced murine acute pancreatitis. Pancreas 2009 0.80
38 Radiofrequency ablation of the pancreas. I: Definition of optimal thermal kinetic parameters and the effect of simulated portal venous circulation in an ex-vivo porcine model. JOP 2005 0.80
39 Insulin protects pancreatic acinar cells from cytosolic calcium overload and inhibition of plasma membrane calcium pump. J Biol Chem 2011 0.80
40 Duodenal duplication cyst with profound elevation of intracystic carbohydrate antigen (CA 19-9) and carcinoembryonic antigen (CEA): a rare but important differential in the diagnosis of cystic tumours of the pancreas. JOP 2006 0.79
41 Recombinant human activated protein C as a disease modifier in severe acute pancreatitis: systematic review of current evidence. Pancreatology 2012 0.79
42 Evaluation of the Manchester classification system for chronic pancreatitis. JOP 2006 0.78
43 Contemporary management of perihilar cholangiocarcinoma in a nontransplant hepatopancreatobiliary center. Eur J Gastroenterol Hepatol 2013 0.78
44 General surgery in patients with a bleeding diathesis: how we do it. World J Surg 2011 0.78
45 Differential kinetics of plasma CD105 and transforming growth factor beta expression early in human acute pancreatitis. Pancreas 2006 0.77
46 Glycolytic ATP fuels the plasma membrane calcium pump critical for pancreatic cancer cell survival. J Biol Chem 2013 0.77
47 Poly(adenylic acid) complementary DNA real-time polymerase chain reaction in pancreatic ductal juice in patients undergoing pancreaticoduodenectomy. Pancreas 2010 0.77
48 Poly(A) cDNA real-time PCR for indicator gene measurement in cancer. Methods Mol Biol 2010 0.77
49 Cytokine profiles in patients receiving antioxidant therapy within the ANTICIPATE trial. World J Gastroenterol 2013 0.77
50 Administration of human recombinant activated protein C is not associated with pancreatic parenchymal haemorrhage in L-arginine-induced experimental acute pancreatitis. JOP 2013 0.76
51 Variance in elective surgery for chronic pancreatitis. JOP 2009 0.76
52 Quantitative analysis of plasma DNA in severe acute pancreatitis. JOP 2006 0.76
53 Pro/con debate: antifungal prophylaxis is important to prevent fungal infection in patients with acute necrotizing pancreatitis receiving broad-spectrum antibiotics. Crit Care 2006 0.76
54 Contemporary management of infected necrosis complicating severe acute pancreatitis. Crit Care 2006 0.76
55 Long-term outcome of patients with chronic pancreatitis treated with micronutrient antioxidant therapy. Hepatobiliary Pancreat Dis Int 2017 0.75
56 Endoscopic versus surgical treatment for chronic pancreatitis. N Engl J Med 2007 0.75
57 Improving definition of the term "synchronous liver metastases" from colorectal cancer. Hepatobiliary Pancreat Dis Int 2016 0.75
58 Laparoscopic biliary bypass and current management algorithms for the palliation of malignant obstructive jaundice. Ann Surg Oncol 2004 0.75
59 Contemporary management of pancreatic pseudocysts. Pancreatology 2005 0.75
60 Erratum to: Preventing Inguinodynia After Hernia Surgery: Does the Type of Mesh Matter? World J Surg 2015 0.75
61 Outcome of hepaticojejunostomy without access loop for repair of iatrogenic bile duct injury at laparoscopic cholecystectomy. J Hepatobiliary Pancreat Surg 2007 0.75
62 Practical strategies for case selection in minimally invasive necrosectomy. Pancreatology 2008 0.75
63 Functional protein C levels during the early phase of clinical acute pancreatitis. Pancreas 2010 0.75